Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorCengiz, Betul
dc.contributor.authorAytekin, Vedat
dc.contributor.authorBildirici, Ulas
dc.contributor.authorSahin, Sukru Taylan
dc.contributor.authorYurdakul, Selen
dc.contributor.authorAytekin, Saide
dc.contributor.authorKucukkaya, Reyhan
dc.date.accessioned2020-12-02T18:01:46Z
dc.date.available2020-12-02T18:01:46Z
dc.date.issued2019
dc.identifier.issn0870-2551
dc.identifier.issn0304-4750
dc.identifier.urihttps://doi.org/10.1016/j.repc.2018.09.014
dc.identifier.urihttp://hdl.handle.net/11446/3720
dc.descriptionWOS: 000503202800001en_US
dc.descriptionPubMed: 31784298en_US
dc.description.abstractIntroduction: Acute coronary syndromes (ACS) mostly occur in patients with traditional risk factors. Especially in young adults without major cardiovascular (CV) risk factors, one of the less common causes of ACS is myeloproliferative neoplasms (MPNs). Methods: We retrospectively collected data on 11 consecutive patients (nine men, two women, mean age 40.18 +/- 8.4 years) with a diagnosis of MPN who presented with ACS. the demographic characteristics of the study population, type of MPN, clinical manifestations, location of myocardial infarction (MI), coronary angiography findings, complete blood count and other related findings, and treatment strategy before and after diagnosis were analyzed. Results: Six patients were diagnosed with polycythemia vera, four with essential thrombocytosis and one with primary myelofibrosis. A JAK2 mutation was found in nine patients. Mean time to diagnosis of MPN was 2.81 years after presenting ACS and mean age at first MI was 32.9 +/- 6 years. Six patients had no major CV risk factors. Ten patients had anterior MI and one had inferior MI. After initiation of specific treatment for MPN, no recurrent thrombotic events were observed in a mean follow-up of 4 +/- 2.44 years. Conclusions: in young adults presenting with ACS, MPNs should be considered, especially in the absence of atherosclerotic coronary artery lesions. It is also important to pay attention to blood cell count abnormalities seen in intracoronary thrombotic events. Early diagnosis and treatment of MPNs is essential to prevent recurrence of thrombotic events and may reduce mortality and morbidity related to thrombotic complications. (C) 2019 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espana, S.L.U.en_US
dc.language.isoengen_US
dc.publisherElsevier Espana Sluen_US
dc.identifier.doi10.1016/j.repc.2018.09.014en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEssential thrombocytosisen_US
dc.subjectAcute coronary syndromeen_US
dc.subjectPolycythemia veraen_US
dc.subjectYoung adultsen_US
dc.titleA rare cause of acute coronary syndromes in young adults - myeloproliferative neoplasms: A case seriesen_US
dc.typearticleen_US
dc.relation.journalRevista Portuguesade Cardiologiaen_US
dc.departmentDBÜen_US
dc.identifier.issue9en_US
dc.identifier.volume38en_US
dc.identifier.startpage613en_US
dc.identifier.endpage617en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Cengiz, Betul; Sahin, Sukru Taylan; Yurdakul, Selen] Istanbul Bilim Univ, Dept Cardiol, Istanbul, Turkey; [Aytekin, Vedat; Aytekin, Saide] Florence Nightingale Hosp, Dept Cardiol, Istanbul, Turkey; [Bildirici, Ulas] Kocaeli Univ, Fac Med, Dept Cardiol, Koaceli, Turkey; [Kucukkaya, Reyhan] Istanbul Bilim Univ, Dept Internal Med, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster